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Abstract
Modern desistance research has examined many facets of desistance, in terms of theoretical
predictors of desistance and recidivism, and in terms of differing types of offending. Though
predicting desistance from illegal drug use is among these topics, no research to date has
examined the predictors of desisting from prescription opioid abuse. This study uses longitudinal
data from 318 prescription opioid users to analyze the effects of various predictors of desistance
on declining nonmedical prescription opioid use, with an emphasis on gender differences among
participants. Results indicate that theoretical and demographic characteristics correspond with
differing rates of decline and further vary by gender.
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The nonmedical use (abuse) of prescription drugs has been a long-standing and growing
problem in the United States. Nonmedical prescription drug use can be defined as use
without a prescription from a doctor or use solely for the feeling or experience caused by the
drug, and includes the use of opiate-type pain relievers, tranquilizers, stimulants, and
sedatives (Substance Abuse and Mental Health Services Administration [SAMHSA],
2006a). In recent years, there has been a sizable increase in the prevalence of nonmedical
prescription drug users, particularly among adolescents and young adults (Gledhill-Hoyt,
Lee, Strote, & Wechsler, 2000; Johnston, O’Malley, Bachman, & Schulenberg, 2006;
Mohler-Kuo, Lee, & Wechsler, 2003; SAMHSA, 2006b). The National Survey of Drug Use
and Health found that the numbers of new nonmedical users of prescription opioids
(primarily products containing codeine, hydrocodone, and oxycodone) increased from
600,000 in 1990 to more than 2.4 million in 2004, making it the drug category with the
largest number of new users that year (Inciardi & Cicero, 2009; SAMHSA & Office of
Applied Studies, 2005). The increase has been so pronounced that recent national survey
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data regarding substance use have indicated that the prevalence of nonmedical prescription
drug use is now greater than the prevalence rates for all other illicit drugs aside from
marijuana (Johnston et al., 2006; McCabe, Teter, & Boyd, 2006; SAMHSA, 2006a). In
addition, the number of new opioid users exceeded new initiates for marijuana (2.1 million)
and cocaine (1.0 million) in 2004 (SAMHSA, 2006a).
Prior studies examining nonmedical prescription drug use have been focused primarily on
addressing the characteristics of the users themselves and the correlates related to their use.
Research has found that those at the greatest risk for use tend to be younger (Johnston et al.,
2006; SAMHSA, 2006a). Similarly, gender differences in use tend to be mixed, with some
studies finding higher prevalence rates in males (Kroutil et al., 2006; McCabe, 2005;
McCabe et al., 2006), whereas others have found higher rates among females (Simoni-
Wastila, Ritter, & Strickler, 2004; Simoni-Wastila & Strickler, 2004; Sung, Richter,
Vaughan, Johnson, & Thom, 2005). Research also indicates that Whites are at an increased
risk for use compared with non-Whites (Ford & Rivera, 2008; Kroutil et al., 2006; McCabe,
2005; McCabe et al., 2006; Simoni-Wastila & Strickler, 2004; Sung et al., 2005). Other
correlates related to increased nonmedical prescription drug use include those with less than
a high school education or college degree (Harrell & Broman, 2009; Huang et al., 2006;
Merline, O’Malley, Schulenberg, Bachman, & Johnston, 2004), unemployed and
nonmarried people (Merline et al., 2004), illicit drug and alcohol users (Kurtz, Inciardi,
Surratt, & Cottler, 2005; Simoni-Wastila et al., 2004), those with more substance-using
peers (Higgins, Mahoney, & Ricketts, 2009; Quintero, 2009), and those with more severe
criminal offending and arrest histories (Ball, Rosen, Flueck, & Nurco, 1982; Goldstein,
1985; Inciardi, 2008; Kurtz et al., 2005; Kurtz, Inciardi, & Pujals, 2009).
Drug Use and the Desistance Process
Although a vast number of recent empirical studies has focused on the process of desistance
from criminal offending, no study to date has examined this process among a contemporary
sample of nonmedical prescription drug users. Prior research has primarily examined the
mediating effect that drug use has between conventional social roles and criminal desistance
(see Schroeder, Giordano, & Cernkovich, 2007), but no study to date has examined those
factors that lead to the cessation from nonmedical prescription drug use. From a theoretical
standpoint, it is therefore unknown whether theories of desistance can be used to explain this
new type of drug user in today’s social and economic context. Most notably, Sampson and
Laub’s age-graded theory of informal social control has emphasized the importance of social
bonds through positive relationships as offering the potential to redirect lives in a more
prosocial direction. Studies examining these relationships have generally found peer
relationships to be influential (Maume, Ousey, & Beaver, 2005; Warr, 1998). While this
study is not meant as a direct test of Sampson and Laub’s (1993) age-graded theory of
informal social control (see also Laub & Sampson, 2003), this theoretical framework serves
as an important starting point in identifying those specific factors that are influential in the
cessation of nonmedical prescription opioid use.
A large body of criminological research has examined the factors related to the cessation of
substance use and crime. An array of empirical evidence supports the notion that criminal
offending and drug use have common causes (Brook & Cohen, 1992; Osgood, Johnston,
O’Malley, & Bachman, 1988; Schroeder et al., 2007; White, Pandina, & LaGrange, 1987;
Zhang, Welte, & Wieczorek, 2002). Laub and Sampson (2001), in a comprehensive review
of the desistance process, concluded that those factors influencing desistance for drug use
and crime are contextually similar. Despite these similarities relating to the cessation of
substance use and crime, researchers have discovered significant differences between the
developmental trajectories of drug users and criminal offenders. Drugs and, possibly more
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contextually important, the drug culture have unique features that can potentially complicate
desistance efforts. Beyond the social-control explanation for the relationship between drugs
and life-course patterns of offending described by Laub and Sampson (2003), research has
stressed the importance in examining peer associations among drug users as impediments to
the desistance process over the life course. Prior research examining the factors relating to
marijuana desistance has found the association with drug-using peers to be a significant
predictor of an individual’s likelihood to stop using marijuana (Esbensen & Elliott, 1994;
Kandel & Raveis, 1989; Lanza-Kaduce, Akers, Krohn, & Radosevich, 1984; Maume et al.,
2005). The influence of drug-using peers has also proved to be a significant factor in the
etiology of marijuana use as well as other illicit substances (Akers & Cochran, 1985; Elliott,
Huizinga, & Menard, 1989; Hawkins, Catalano, & Miller, 1992; Jessor, Chase, & Donovan,
1980; Marcos, Bahr, & Johnson, 1986; Ousey & Maume, 1997).
Other studies have stressed the importance of the influence of prior criminality on the
desistance process. Although existing literature suggests that an individual’s prior offending
is a strong predictor of future offending (e.g., Nagin & Paternoster, 1991), few existing
studies have controlled for these factors (e.g., arrest history) when evaluating explanations
of desistance, particularly among drug-involved samples. That being said, the theoretical
perspectives that frame the majority of studies examining the desistance process (i.e., age-
graded social-control and self-control theories) are general explanatory models that can
apply to criminal offending and substance-using behaviors. The analysis that we describe
focuses on an as of yet unexplored area of desistance and drug use: nonmedical prescription
opioid use.
The current study contributes to research on substance abuse by examining those factors that
impede and accelerate the desistance process from nonmedical prescription opioid use.
Many studies define desisters as individuals who have not reoffended over a certain period
of time, which can range from 1 year to several years (see, for example, Bushway, Piquero,
Broidy, Cauffman, & Mazerolle, 2001; Maruna, 2001; Warr, 1998). This static approach to
operationalizing desistance as an event as opposed to a process has been inconsistent
regarding recent arguments in the life-course literature (see Bushway et al., 2001; Giordano,
Cernkovich, & Rudolph, 2002; Laub & Sampson, 2003). Other studies have argued that
desistance should not be understood as a permanent or static condition but rather understood
and conceptualized as a process or as “a work in progress” (Bushway et al., 2001; Maruna,
2001). The usage patterns of drug use makes examining a static form (e.g., user vs. nonuser)
of desistance difficult. As is the case with most dependent or recreational illicit drug users,
true desistance or cessation is a dynamic process that often involves a sequence of
unsuccessful attempts to quit before long-term abstinence is achieved (Zhou et al., 2009).
Thus, operationalizing desistance as a state of nonoffending rather than considering it as a
gradual changing process in terms of the reduction of severity of offending behavior may
not be appropriate for illicit drug users (Chu & Sung, 2009). Understanding that a prolonged
state of abstinence is unlikely given the high probability of relapse among a sample of
nonmedical prescription opioid users, this study operationalizes desistance using a more
realistic harm-reduction approach of declining use.
Using four waves of structured interview data derived from a sample of ethnically diverse
polydrug users recruited using respondent-driven sampling (see Heckathorn 1997, 2002) in
Miami-Dade County, Florida, this study assesses and compares the influence of multiple
social, criminal history, and demographic variables on the likelihood of exhibiting a model
of desistance, persistence, or an unstable/episodic pattern of prescription opioid use. This
study is particularly important as it utilizes a contemporary sample of ethnically diverse men
and women, whereas prior studies of desistance have relied heavily on samples of
delinquent males who were coming of age during a time of economic growth and prosperity
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in the 1950s and 1960s (i.e., Glueck & Glueck, 1950).1 It is therefore unknown whether the
traditional explanations for desistance can be extended to explain behavior in today’s social
and economic context regarding a contemporary type of drug user. While this is by no
means an explicit test of the traditional theories of desistance, it is meant as an exploratory
study examining some of the factors potentially related to desistance/declining use among a
diverse contemporary sample of nonmedical prescription opioid users in the club culture.
Method
Data Collection and Sample
The data used in this study come from the South Beach Project, which has a sample of 600
ethnically diverse polydrug users recruited in Miami-Dade County, Florida. Initial
participants (“seeds”) were recruited through outreach in nightclub districts, as well as
advertisements in alternative print media. These 81 seeds were then used to recruit referrals
using respondent-driven sampling (Heckathorn, 1997, 2002). Each participant was given
“coupons” for referrals up to a maximum of five coupons/referrals. If a new participant
presented a coupon associated with a prior participant, the prior participant would receive
US$50. Participants were asked to give the coupons only to people in their social networks
with whom they had used drugs in the past 90 days. The first baseline interviews began in
May 2006 and continued through June 2008 until 600 participants had been interviewed.
Follow-up interviews were conducted at 6 months, 12 months, and 18 months postbaseline.
These interviews were attempted with all participants regardless of whether participants had
missed a previous follow-up. The retention rates for the follow-up interviews were 81%,
77%, and 77%, respectively. Interviews lasted approximately 2 to 3 hr and participants were
paid US$50 for each interview in which they participated.
The median age among the participants was 24 years old, though the sample targeted all
ages from 18 to 49. Participants were ethnically diverse, including 21% non-Hispanic White,
25% non-Hispanic Black, 54% Hispanic, and 3% Other. The sample contained slightly more
males than females, with 59% male and 40% female. In addition, three individuals identified
as trans-gendered rather than male or female.
Each baseline interview was conducted using computer-assisted, interviewer-administered,
standard instrumentation. The primary instrument was the Global Appraisal of Individual
Needs (GAIN; Dennis, Titus, White, Unsicker, & Hodgkins, 2002). Only a few
modifications were made to the baseline (GAIN-I) and follow-up (GAIN-M90) instruments
for the study. Changes relevant to the present study included (a) increasing the number of
drug categories so as to clearly delineate a wide variety of prescription and illicit drugs and
(b) greater detail regarding age and sequence of onset, recency, frequency, and heavy
periods of use for each drug. For substance use, baseline and follow-up instruments include
measures of past 90-day behavioral counts.
The present study uses select data from all four timepoints to estimate desistance patterns for
nonmedical prescription opioid use. As such, some cases were not used for analyses in the
present study. First, only participants who reported using opioids at baseline were retained.
This resulted in a reduced data set of 345 participants. In addition, because this study
addresses change over time, only participants with at least two timepoints of data (baseline
and at least one follow-up) are included in these analyses (92% of cases). This further
reduced the sample to 318 participants. In terms of opioid use, the participants who did not
participate in a follow-up interview were not significantly different from those who did in a t
1For alternative studies that have examined the desistance process among contemporary samples, see Giordano, 2010; Giordano,
Cernkovich, and Rudolph, 2002; and Maruna, 2001.
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test comparing these groups (p = .49). The sample continues to be slightly more male (56%)
and ethnically diverse (22% White, 30% Black, 46% Hispanic, and 3% Other). The age has
a median of 25 and a mean of 27.
Variables
The main variables of interest are measures of opioid use at each timepoint. The survey
asked participants about a variety of opioids, including codine, propoxyphene, meperidine,
fentanyl, hydrocodone, hydromorphone, methadone, morphine, OxyContin, other
oxycodone, pentazo-cine, tramadol, and “all other Rx opioids.” Two questions relating to
each of these opioids are used for the present study: “During the past 90 days, on how many
days have you used [drug name]” and “What was the strength in milligrams of the [drug
type] that you usually took?” The latter question included a drug-specific dosage chart to
assist participants in selecting the appropriate response.
To transform these variables into a single, continuous variable, several steps were taken.
First, the dosage responses were transformed, separately, into z scores and adjusted using
the following equation:
This results in a variable for each drug that has a mean of 1 and ranges from 0.6 to 1.4,
which measures the dose for each drug relative to the dose used by other users of the same
drug. The next step used was to multiply this dosage variable with the number of days the
participant used the specific drug, resulting in a dose-adjusted frequency. Because desistance
could be confounded by users switching the specific drug used from one type of opioid to
another, these variables were then combined by summing the variables together. Though this
is not a measure of days of opioid use, it is largely based on the number of days and may be
thought of as a number of days measure adjusted for dosage and multiple types of opioids.
Due to a high positive skew, the resulting variable was capped at 90. This value was chosen
because most cases (>90%) scored below 90 and, given that the number is an adjust number
of days measure, it was a natural selection for a maximum. Thus, the final variables (one for
each timepoint) range from 0 to 90 and provide single measures capturing frequency, variety
of opioid types, and dosage. The descriptive statistics for this and other measures are
included in Table 1.
Predictor variables in the model include baseline measures of peer use, perceptions of harm,
perceptions of punishment, and criminal history. Peer use was measured using the question,
“How many of your friends would you estimate use sedatives or painkillers to relax or get
high (not as prescribed)?” Responses included none (0), a few (1), some (2), most (3), and
all (4). Perceptions of harm was measured using the question, “How much do you thing
people risk harming themselves (physically or in other ways) if they take sedatives or
painkillers twice a week to relax or get high (not as prescribed)?” Responses included no
risk (0), slight risk (1), moderate risk (2), and great risk (3). Perceptions of punishment was
measured using the question, “How likely is it that you would get in trouble with police if
you were stopped while driving and had five sedative or painkiller pills and no
prescription?” Responses included very unlikely (0), unlikely (1), not sure (2), likely (3),
and very likely (4).
Criminal history measures include measures of arrests, convictions, and violent history. The
measure for arrests counts the number of self-reported arrests in the participant’s lifetime in
which the participant was arrested and charged with a crime. Arrests in which the case was
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dropped prior to trial are still counted as long as the participant was charged at some point.
The measure for convictions is a count of self-reported convictions or adjudications. For
both arrests and convictions, the number is not contingent on the severity or type of offense.
Violent history is a dichotomous variable indicating whether the participant had ever been
charged with robbery, aggravated assault, forcible rape, murder/homicide/manslaughter, or
arson.
Several demographic characteristics are also included. They include dichotomous indicators
of being female, Black, Hispanic, and having completed a high school degree or General
Educational Development (GED). A dichotomous indicator of a race/ethnicity that is not
White, Black, or Hispanic (“Other”) was originally included but had to be removed due to
convergence problems relating to having so few cases with that attribute.
Analytic Strategy
To estimate change over time, this study uses MPlus to estimate growth models based on
these data. This approach estimates an intercept predicting baseline opioid use and a slope
estimating a linear change over time. Timepoints used for this linear change are the number
of months since baseline (i.e., 0, 6, 12, and 18). A nonlinear, quadratic change was estimated
but was a poor fit and resulted in a failure to converge. The models presented are estimated
using maximum likelihood (ML) estimations. Models were also run using ML with robust
standard errors (not presented) to address the nonnormally distributed opioid variables but
did not significantly improve model fit and therefore were abandoned in favor of standard
ML estimations.
Baseline predictors are included in the model as time-invariant covariates and are used to
predict the intercept and slope. Perceptions of harm and peer use were also measured during
follow-up interviews and theoretically could be considered time-varying covariates.
However, due to little change within persons, these variables are included postbaseline only
as a measure of change since baseline. This allows opioid use to be estimated while
controlling for changes in these perceptions but without affecting the inclusion of the
baseline measures as time-invariant covariates. A dichotomous measure indicating whether
the participant had been arrested since the previous interview is also included as a time-
varying covariate at each timepoint. A graph of the model is presented in Figure 1. Given
that prior research has demonstrated gender differences in those factors contributing to the
desistance process for males and females, these models were also estimated separately for
males and females as an exploratory step for examining gender differences (see Giordano et
al., 2002; Uggen & Kruttschnitt, 1998).
Results
The fit statistics for the overall model were mixed. The chi-square statistic indicated good fit
(χ2/df = 2.017), as did the standardized root mean square residual (SRMR = .032). The
comparative fit index (CFI), conversely, indicated poor fit (CFI = .824). Given that two of
these three measures indicated good fit, no modifications were made from the hypothesized
model. Substantively, the model predicts an average starting point of 21.072 for opioid use
and an average monthly decline of 0.967. This results in an estimated decline in nonmedical
opioid use from 21.1 to 3.7 over the course of the study. In addition, the interaction between
the intercept and slope (−.020) indicates that the higher the predicted intercept is for an
individual, the steeper their slope, thus indicating partial convergence over time between
high and low opioid users. For example, an individual 1 unit higher at the intercept would be
expected to be 0.64 units higher by the end of the study. The full results for the model
estimated with the entire sample are presented in Table 2.
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Beginning with the theoretically relevant variables, the measure of peer use has a significant
impact on the intercept (5.76). This indicates that an individual 1 unit higher than the mean
on this 5-point scale is predicted to be nearly 6 points higher on the Opioid Use scale.
Though this variable’s effect on the slope is not statistically significant, its cumulative effect
by the 18th month is substantive. An individual 1 point higher than the mean for peer use
would be expected to decline from a 5.76 unit difference in opioid use at baseline, to a 2.50
unit difference 18 months later.
The coefficients for perceived harm indicate a continuing impact on opioid use. At baseline,
an individual who reported perceiving harm of prescription drug use without a prescription
at 1 point higher than the mean for this 4-point scale is likely to be using opioids less often
than the average user (−3.30). Moreover, this effect appears to be a cumulative effect
throughout the study. Though nonsignificant, the impact of perceived harm on the slope is
also negative. This indicates that the aforementioned hypothetical individual would not only
start with lower opioid use (−3.30), he or she would end with lower opioid use as well
(−3.70).
Unlike the measures of perceived peer use and perceived risk of harm, the perception of
punishment for being found with prescription drugs does not appear to have a significant
impact on opioid use. Those who perceived punishment to be 1 unit more likely on the scale
than average do not use significantly less opioids than those at the mean. In fact, the
nonsignificant effect indicates they are estimated to use more opioids (1.09 at baseline),
though the impact on the slope (−0.04) reverses most of this difference (0.29 at 18 months).
Neither the number of reported prior arrests nor the number of reported prior convictions
appears to have a significant influence on the amount of opioid use. Similarly, a self-
reported conviction for a violent offense did not significantly impact the intercept or the
slope.
Select background characteristics were significant predictors of the degree of opioid use.
Individuals who were Black or Hispanic are predicted to use significantly less opioids than
Whites (−10.77 and −15.85, respectively). Interestingly, the strong positive effects on the
slope indicate these differences disappear over time. For Blacks, this means a near-complete
convergence with Whites (−0.40 by the 18th month), whereas for Hispanics, it means the
difference is roughly halved (−15.85 at baseline to −7.59 at 18 months).
Older individuals tended to engage in more opioid use than the young. For year, older an
individual reported being, he or she is estimated to be 0.40 units higher on the Opioid Use
scale. Moreover, the effect of age on the slope is nonsignificant, which indicates that this
effect does not lessen over time and older individuals continue to use more opioids than the
young.
The remaining demographic variables, having a high school degree and gender, did not have
a significant impact on the intercept. However, being female did have a significant impact
on the slope. This indicates that females start out lower than the males for opioid use but end
with more opioid use than the males. This reversing role will be further explored with the
separate gender models.
The effects of the time-varying covariates, including changes in perceived peer use, changes
in perceived risk of harm, and having been recently arrested, are also presented with the
results for the full model. Because these are included primarily as control variables, these
relationships will not be fully explored. However, it is worth noting that effects of changes
in peer use are significant at 6 and 12 months, and in the expected direction. Thus, declines
in perceived peer use correspond to decline in the participant’s peer use as well.
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The gender-specific models are presented in Table 3. Overall, the model predicts similar
slopes for males and females (−1.17 and −0.84, respectively), but different starting points on
the intercept (24.24 for males and 16.98 for females). Thus, males start with greater opioid
use than females and consistently use more after controlling for other factors. However, as is
evident in a visual representation of the model (see Figure 2), the male and female slope do
converge after taking into account the exogenous variables. For males, the interaction
between the intercept and the slope continues to be significant, indicating that males with
more opioid use have steeper declines than males with lower levels of opioid use.
As with estimates for the entire sample, males and females tend to score roughly 6 points
higher (6.3 and 6.1, respectively) on the Opioid Use scale for every 1 point higher on the
Peer Use scale. Though the effect on the slope remains nonsignificant for both groups, and
there is no significant difference between groups, the effect of peer use on the slope is
roughly 3 times as much for females as it is for males. Thus, the effect of peer use seems to
diminish over time for females (6.12 at baseline, 0.65 at 18 months), whereas remains
present for males (6.32 at baseline, 4.67 at 18 months).
With regard to perceptions of harm, the effect on the intercept does not appear to differ from
the previous model. Though the effect is now nonsignificant, the substantive impact remains
similar. Thus, the decrease in significance is likely the result of a loss of power from halved
sample sizes in this group-specific model. The direction of the effect of peer use on the slope
varies by gender, indicating that the effect of perceived harm on opioid use decreases over
time for males, whereas increases over time for females. However, as with the full sample,
the effect of perceived harm on the slope is not significant.
For demographic characteristics, the effect of being Hispanic does not appear to vary
significantly by gender in comparison with the overall model. For males and females,
Hispanics are predicted to use less opioids than Whites. Conversely, the effect for being
Black does show some differences by gender, albeit not significantly. For males, being
Black results in a higher intercept and the effect only partially diminishes over time (−15.36
at baseline, −7.60 at 18 months). For females, being Black decreases the intercept by a
smaller amount and the effect is reversed thereafter (−4.36 at baseline, 9.15 at 18 months).
For age, older males tend to use more opioids than younger males at baseline (0.562 per
year), but the effect is nearly halved within 18 months. For females, there is no significant
difference by age.
Other variables in the model continue to be nonsignificant in the gender-specific models.
These include number of arrests, number of convictions, violent conviction, and high school
degree. Among the time-varying covariates (not shown) for males, changes in peer use and
having a new arrest are significant at 6 months and changes in perceived harm is significant
at 18 months. For females, only having a new arrest at 6 months is significant.
Discussion
Prior literature has suggested that opioid use and nonmedical prescription drug use in
general have become rivals with nonprescription illicit drug use in terms of prevalence (e.g.,
SAMHSA, 2006b). There has been, however, little to no research examining whether users
of prescription drugs experience the same desistance process or whether they are subject to
the same influences of desistance in comparison with users of illicit drugs or users in
previous generations. Similarly, prior studies of desistance have relied primarily on male
samples that came of age in a much different social and economic context than the sample
utilized in this study (i.e., Glueck & Glueck, 1950). This study sought to provide an
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exploratory examination of a diverse group of nonmedical prescription opioid users and
their desistance process.
The results indicate similarities and dissimilarities to prior studies on nonmedical
prescription drug use and among desistance studies of criminal offending and drug use.
Males and females, for example, were typically using more opioids if they reported that their
friends were also using, which is consistent with prior research on the effect of peer use
(Higgins et al., 2009; Quintero, 2009). Prior studies examining desistance from substance
use has found the association with drug-using peers to be a significant predictor of an
individual’s likelihood to stop using the illicit substances (Esbensen & Elliott, 1994;
Hawkins et al., 1992; Kandel & Raveis, 1989; Lanza-Kaduce et al., 1984; Maume et al.,
2005; Ousey & Maume, 1997). Consistent with these studies that primarily examined
alcohol and marijuana, an association with antisocial or drug-using peers was also found to
impede the desistance process for nonmedical prescription opioid users. Thus, those
individuals who had prescription opioid–using peers were less likely to desist as quickly
from their own use compared with those with nonprescription opioid–using peers. This
supports the life-course perspective, which stresses the importance of social bonds, positive
and negative, in redirecting drug-using trajectories in a prosocial or antisocial direction.
The overall findings for race—that Blacks and Hispanics are using less prescription opioids
than Whites—are consistent with research in the area of nonmedical prescription drug use
(Ford & Rivera, 2008; Kroutil et al., 2006; McCabe, 2005; McCabe et al., 2006; Simoni-
Wastila & Strickler, 2004; Sung et al., 2005). Also similar to prior research (Ball et al.,
1982; Goldstein, 1985; Inciardi, 2008; Kurtz et al., 2009), this study found that males with
more extensive criminal histories (arrests) typically desist at a slower pace. This is
supportive of the criminal stability hypothesis, emphasizing the role that an individual’s
prior offending has on future offending (e.g., Nagin & Paternoster, 1991). On the contrary,
however, these findings indicate that prior convictions have the opposite effect and that
neither relationship is found among female users. Whereas traditionally education has
played a role in drug use (Harrell & Broman, 2009; Huang et al., 2006; Merline et al., 2004),
the present data suggest no such relationship. In addition, despite traditional drug
involvement theoretically being related to the perception of harm and the perception of
punishment, these relationships were also nonsignificant among these users in terms of
predicting desistance.
These findings are not without limitations. First, the sample was limited to multidrug-
involved club patrons in South Beach, Miami. Though there is no evidence to suggest these
prescription opioid users are different from other prescription opioid users, there is similarly
no evidence to suggest they are the same. A sample that reaches other populations of
nonmedical prescription opioid users would invoke more confidence in its generalizability.
Second, the data are limited entirely to self-report data. While the high reported levels of
prescription drug abuse would appear to indicate that the respondents are not attempting to
hide their use, its accuracy and full honesty cannot be guaranteed. Third, though the
retention rate is reasonably high (92% participated in at least one follow-up), there is always
a danger in attrition of any kind that nonresponses are related to the variables of interest. In
this case, it is possible that nonresponse is related to substance use or its consequences,
though no significant differences at baseline were observed.
Overall, these findings suggest a need for additional research in the area of nonmedical
prescription drug use desistance. With similarities and dissimilarities to prior desistance
research uncovered in this exploratory study, additional research is necessary to fully
understand these relationships. For example, the positive relationship between arrests and
use and the negative relationship between convictions and use suggests the involvement of
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sentencing may influence desistance after the fact; additional research is needed to fully
understand this relationship. Moreover, the findings suggest racial differences, with White
users typically using more than Black or Hispanic users. However, determining whether the
effects of the theoretical predictors vary by race was beyond this study’s scope. Future
research should more fully address the potential differences by race.
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Figure 1.
Growth model
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Figure 2.
Declining opioid use by gender
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Table 1
Descriptive Statistics
M SD Minimum Maximum
Opioid use–Time 1 25.067 29.461 0.65 90.00
Opioid use–Time 2 11.001 22.297 0.00 90.00
Opioid use–Time 3 7.999 19.055 0.00 90.00
Opioid use–Time 4 5.306 16.742 0.00 90.00
Peer use 1.915 0.924 0.00 4.00
Perceived harm 1.550 0.967 0.00 3.00
Punishment 2.745 1.318 0.00 4.00
Arrests 4.255 7.854 0.00 80.00
Convictions 2.791 5.983 0.00 58.00
Violent 0.160 0.368 0.00 1.00
High school education 0.789 0.408 0.00 1.00
Female 0.437 0.497 0.00 1.00
Age 27.327 8.297 18.00 51.00
Black 0.305 0.461 0.00 1.00
Hispanic 0.462 0.499 0.00 1.00
Peer use–Time 2 −0.117 1.069 −4.00 4.00
Peer use–Time 3 −0.574 1.264 −4.00 3.00
Peer use–Time 4 −0.500 1.265 −4.00 3.00
Harm–Time 2 0.137 0.942 −3.00 3.00
Harm–Time 3 0.221 1.130 −3.00 3.00
Harm–Time 4 0.313 1.138 −3.00 3.00
Arrests–Time 2 0.221 0.412 0.00 1.00
Arrests–Time 3 0.147 0.355 0.00 1.00
Arrests–Time 4 0.130 0.337 0.00 1.00
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Table 2
Growth Models
b SE
Intercept
 Peer use 5.758 1.534**
 Perceived harm −3.303 1.463*
 Punishment 1.086 1.017
 Arrests −0.380 0.270
 Convictions 0.354 0.392
 Violent 7.447 3.966
 High school degree −3.395 3.331
 Female −4.028 2.756
 Black −10.767 3.463**
 Hispanic −15.850 3.154**
 Age 0.405 0.172*
Slope
 Peer use −0.181 0.096
 Perceived harm −0.022 0.084
 Punishment −0.044 0.049
 Arrests 0.015 0.014
 Convictions −0.018 0.020
 Violent −0.223 0.205
 High school degree 0.187 0.163
 Female 0.278 0.134*
 Black 0.576 0.189**
 Hispanic 0.459 0.203*
 Age −0.007 0.009
 Intercept −0.020 0.008*
Opioids
 Intercept 15.907 6.992*
 Slope −0.491 0.365
Opioids (6 months)
 Peer use 2.448 1.178*
 Perceived harm −1.144 1.335
 Arrested −1.547 2.460
Opioids (12 months)
 Peer use 1.803 0.837*
 Perceived harm −0.883 0.972
 Arrested 4.431 2.498
Opioids (18 months)
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b SE
 Peer Use −1.145 0.938
 Perceived harm −0.695 1.063
 Arrested 2.662 2.614
Means
 Intercept 21.072 —
 Slope −0.967 —
*
p < .05.
**
p < .01.
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Table 3
Growth Model by Gender
Males Females
b SE b SE
Intercept
 Peer use 6.322 2.227** 6.125 2.137**
 Perceived harm −3.595 2.120 −2.608 1.972
 Punishment 0.640 1.457 1.882 1.398
 Arrests −0.274 0.300 −0.922 1.236
 Convictions 0.066 0.446 1.849 1.143
 Violent 8.284 4.956 3.503 7.641
 High school degree −4.373 4.669 1.425 4.762
 Black −15.359 4.768** −4.364 5.202
 Hispanic −16.534 4.437** −13.813 4.738**
 Age 0.562 0.253* 0.213 0.231
Slope
 Peer use −0.092 0.097 −0.0304 0.185
 Perceived harm −0.036 0.082 0.061 0.148
 Punishment −0.059 0.045 −0.086 0.097
 Arrests 0.021 0.010* 0.005 0.083
 Convictions −0.036 0.016* −0.034 0.085
 Violent −0.081 0.177 −0.053 0.497
 High school degree 0.072 0.153 0.379 0.310
 Black 0.431 0.184* 0.751 0.340*
 Hispanic 0.279 0.184 0.714 0.411
 Age −0.014 0.009 −0.001 0.015
 Intercept −0.031 0.007** −0.007 0.019
Opioids
 Intercept 15.268 10.120 6.438 9.864
 Slope 0.113 0.345 −0.867 0.640
Means
 Intercept 24.242 — 16.985 —
 Slope −1.117 — −0.814 —
Note: Estimates for time-varying covariates, which are included as control variables in these model, are not shown here to conserve space.
*
p < .05.
**
p < .01.
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